The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
Open accessAbstract
Dapagliflozin, a new type of drug used to treat diabetes mellitus (DM), is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Although some studies showed that SGLT2 inhibition attenuated reactive oxygen generation in diabetic kidney the role of SGLT2 inhibition is unknown. We evaluated whether SLT2 inhibition has renoprotective effects in ischemia-reperfusion (IR) models. We evaluated whether dapagliflozin reduces renal damage in IR mice model. In addition, hypoxic HK2 cells were treated with or without SGLT2 inhibitor to investigate cell survival, the apoptosis signal pathway, and the induction of hypoxia-inducible factor 1 (HIF1) and associated proteins. Dapagliflozin improved renal function. Dapagliflozin reduced renal expression of Bax, renal tubule injury and TUNEL-positive cells and increased renal expression of HIF1 in IR-injured mice. HIF1 inhibition by albendazole negated the renoprotective effects of dapagliflozin treatment in IR-injured mice. In vitro, dapagliflozin increased the expression of HIF1, AMP-activated protein kinase (AMPK), and ERK and increased cell survival of hypoxic HK2 cells in a dose-dependent manner. In conclusion, dapagliflozin attenuates renal IR injury. HIF1 induction by dapagliflozin may play a role in renoprotection against renal IR injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Conde, E., Alegre, L., Blanco-Sánchez, I., Sáenz-Morales, D., Aguado-Fraile, E., Ponte, B., Ramos, E., Sáiz, A., Jiménez, C., Ordoñez, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033258 · Cited by 163
Research works printed but not linked: 30
- M Veroux, 2009, Acute renal failure due to ureteral obstruction in a kidney transplant recipient with Candida albicans contamination of preservation fluid, Transpl Infect Dis, 11, 266, 10.1111/j.1399-3062.2009.00388.x · doi:10.1111/j.1399-3062.2009.00388.x
- M Fernando, 2014, Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation, Biomark Med, 8, 1247, 10.2217/bmm.14.86 · DOI
- SR Vercauteren, 2003, Acute ischemia/reperfusion injury after isogeneic kidney transplantation is mitigated in a rat model of chronic renal failure, Am J Transplant, 3, 570, 10.1034/j.1600-6143.2003.00117.x · doi:10.1034/j.1600-6143.2003.00117.x
- DE Choi, 2009, Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats, American journal of physiology Renal physiology, 297, F362, 10.1152/ajprenal.90609.2008 · doi:10.1152/ajprenal.90609.2008
- AM Versteilen, 2004, Molecular mechanisms of acute renal failure following ischemia/reperfusion, Int J Artif Organs, 27, 1019, 10.1177/039139880402701203 · DOI
- M Nangaku, 2008, Hypoxia and hypoxia-inducible factor in renal disease, Nephron Exp Nephrol, 110, e1, 10.1159/000148256 · DOI
- VH Haase, 2006, Hypoxia-inducible factors in the kidney, American journal of physiology Renal physiology, 291, F271, 10.1152/ajprenal.00071.2006 · DOI · Paper page
- O Baranova, 2007, Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia, J Neurosci, 27, 6320, 10.1523/JNEUROSCI.0449-07.2007 · DOI · Paper page
- RS Adluri, 2011, Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1alpha transcription factor and its target genes in mice, Antioxid Redox Signal, 15, 1789, 10.1089/ars.2010.3769 · DOI
- JY Guo, 2011, Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway, J Biomed Sci, 18, 79, 10.1186/1423-0127-18-79 · DOI
- A Weidemann, 2008, HIF activation protects from acute kidney injury, J Am Soc Nephrol, 19, 486, 10.1681/ASN.2007040419 · DOI · Paper page
- CH Yeh, 2010, Hypoxic preconditioning reinforces HIF-alpha-dependent HSP70 signaling to reduce ischemic renal failure-induced renal tubular apoptosis and autophagy, Life Sci, 86, 115, 10.1016/j.lfs.2009.11.022 · DOI
- G Schley, 2012, Selective stabilization of HIF-1alpha in renal tubular cells by 2-oxoglutarate analogues, Am J Pathol, 181, 1595, 10.1016/j.ajpath.2012.07.010 · DOI
- JR Zapata-Morales, 2014, Hypoxia-inducible factor-1alpha (HIF-1alpha) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia, The Journal of biological chemistry, 289, 346, 10.1074/jbc.M113.526814 · DOI
- U Panchapakesan, 2013, Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy?, PloS one, 8, e54442, 10.1371/journal.pone.0054442 · DOI · Paper page
- AT Layton, 2016, Predicted Consequences of Diabetes and SGLT Inhibition on Transport and Oxygen Consumption along a Rat Nephron, American journal of physiology Renal physiology
- J O'Neill, 2015, Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats, American journal of physiology Renal physiology, 309, F227, 10.1152/ajprenal.00689.2014 · DOI · Paper page
- YK Chang, 2009, Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects, J Urol, 181, 1434, 10.1016/j.juro.2008.10.105 · DOI
- KW Lee, 2009, Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity, Toxicology, 257, 137, 10.1016/j.tox.2008.12.017 · doi:10.1016/j.tox.2008.12.017
- L Gunaratnam, 2009, HIF in kidney disease and development, J Am Soc Nephrol, 20, 1877, 10.1681/ASN.2008070804 · DOI · Paper page
- VH Haase, 2006, The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease, Kidney Int, 69, 1302, 10.1038/sj.ki.5000221 · DOI · Paper page
- R Cursio, 2008, Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats, Transplant Proc, 40, 2042, 10.1016/j.transproceed.2008.05.037 · doi:10.1016/j.transproceed.2008.05.037
- AR Knudsen, 2012, Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion, Am J Physiol Gastrointest Liver Physiol, 303, G482, 10.1152/ajpgi.00337.2011 · doi:10.1152/ajpgi.00337.2011
- P Hill, 2008, Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury, J Am Soc Nephrol, 19, 39, 10.1681/ASN.2006090998 · DOI · Paper page
- H Song, 2015, The NADPH oxidase inhibitor DPI can abolish hypoxia-induced apoptosis of human kidney proximal tubular epithelial cells through Bcl2 up-regulation via ERK activation without ROS reduction, Life Sci, 126, 69, 10.1016/j.lfs.2015.02.004 · DOI
- CC Yang, 2009, Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling, Transplantation, 88, 1251, 10.1097/TP.0b013e3181bb4a07 · DOI
- N Nakamura, 2015, Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation, Diabetol Metab Syndr, 7, 48, 10.1186/s13098-015-0044-1 · DOI
- K Morrisey, 1999, Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent, Kidney Int, 55, 2548, 10.1046/j.1523-1755.1999.00454.x · DOI
- M Lee, 2003, AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells, The Journal of biological chemistry, 278, 39653, 10.1074/jbc.M306104200 · DOI · Paper page
- E Minet, 2000, ERK activation upon hypoxia: involvement in HIF-1 activation, FEBS Lett, 468, 53, 10.1016/S0014-5793(00)01181-9 · DOI · Paper page
Cited by
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Heerspink, H. J. L., Kosiborod, M., Inzucchi, S. E., & Cherney, D. Z. I. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.027 · Cited by 393
van Bommel, E. J. M., Muskiet, M. H. A., van Baar, M. J. B., Tonneijck, L., Smits, M. M., Emanuel, A. L., Bozovic, A., Danser, A. H. J., Geurts, F., Hoorn, E. J., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.09.013 · Cited by 363
Metadata
- Authors
- Chang, Y.-K., Choi, H., Jeong, J. Y., Na, K.-R., Lee, K. W., Lim, B. J., & Choi, D. E.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-07-08
- Volume
- 11
- Issue
- 7
- Pages
- e0158810
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2465054738
- Cited by
- 176
- References
- 2
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-07-28)
- Open access
- gold
- Funders
- Catholic University of Korea (CMCDJ-A-2015–020)
- Yonsei University college of medicine (6-2009-0103)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury. https://app.cochat.ai/papers/10.1371/journal.pone.0158810
- The paper
- Chang, Y.-K., Choi, H., Jeong, J. Y., Na, K.-R., Lee, K. W., Lim, B. J., & Choi, D. E. (2016). Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury. PLOS ONE. https://doi.org/10.1371/journal.pone.0158810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.